An analysis of T cell responsiveness in Indian kala-azar
- PMID: 3100620
An analysis of T cell responsiveness in Indian kala-azar
Abstract
The inability of most untreated patients with Kala-azar to control their visceral infections with Leishmania donovani has been attributed to a defective cell-mediated immune response to leishmanial antigens. We examined the in vitro response of T cells, including Leu-2+-depleted T cell populations, to determine whether unresponsiveness could be reversed. These studies on patients with visceral leishmaniasis in Bihar, north India, support previous observations regarding T cell unresponsiveness in patients with active disease: it is profound, it is specific, and it is reversible after successful chemotherapy. However, these studies also indicate that the specific unresponsiveness cannot be reversed by depletion of "suppressor" Leu-2+ T lymphocytes, nor by the addition of exogenously supplied human IL 2 to the cultures. One interpretation of these results is that in active cases of Kala-azar, there is an absence of Leishmania-specific T cells in the periphery. The possibility that reactive cells can be found in situ cannot be excluded. The observation that 13 of 25 family members of active cases were able respond to L. donovani in vitro or by skin testing suggests that the frequency of infection within an endemic area in Bihar is very high, and that assays for T cell responsiveness are far better epidemiologic tools for the detection of asymptomatic infection than is ELISA. Identification of such an exposed, Kala-azar-resistant population will be required to study host factors which influence the development of disease in infected individuals.
Similar articles
-
Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.J Pathol. 1999 Dec;189(4):615-22. doi: 10.1002/(SICI)1096-9896(199912)189:4<615::AID-PATH466>3.0.CO;2-Z. J Pathol. 1999. PMID: 10629566
-
Potential role for interleukin-10 in the immunosuppression associated with kala azar.J Clin Invest. 1993 Dec;92(6):2626-32. doi: 10.1172/JCI116878. J Clin Invest. 1993. PMID: 8254019 Free PMC article.
-
Epidemiology of visceral leishmaniasis in India.Natl Med J India. 1999 Mar-Apr;12(2):62-8. Natl Med J India. 1999. PMID: 10416321 Review.
-
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100. Exp Parasitol. 1996. PMID: 8932764
-
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.
Cited by
-
Leishmania donovani-specific 25- and 28-kDa urinary proteins activate macrophage effector functions, lymphocyte proliferation and Th1 cytokines production.Parasitol Res. 2013 Apr;112(4):1427-35. doi: 10.1007/s00436-013-3272-z. Epub 2013 Jan 19. Parasitol Res. 2013. PMID: 23334693
-
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.Clin Vaccine Immunol. 2012 Jun;19(6):961-6. doi: 10.1128/CVI.00143-12. Epub 2012 Apr 25. Clin Vaccine Immunol. 2012. PMID: 22539471 Free PMC article.
-
CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis.Immunology. 2004 Oct;113(2):260-8. doi: 10.1111/j.1365-2567.2004.01948.x. Immunology. 2004. PMID: 15379987 Free PMC article.
-
Leishmaniasis: current status of vaccine development.Clin Microbiol Rev. 2001 Apr;14(2):229-43. doi: 10.1128/CMR.14.2.229-243.2001. Clin Microbiol Rev. 2001. PMID: 11292637 Free PMC article. Review.
-
The role of mucosal-associated invariant T cells in visceral leishmaniasis.Front Immunol. 2022 Sep 15;13:926446. doi: 10.3389/fimmu.2022.926446. eCollection 2022. Front Immunol. 2022. PMID: 36189274 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials